Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Should you bet on an established giant or a pipeline-driven innovator? This comparison examines Amgen (NASDAQ:AMGN) and Moderna…
‘No longer proven to outweigh its risks’: Ireland pulls medication linked to 20 deaths in Japan
A medication used to treat rare autoimmune diseases has been pulled from shelves in Ireland after regulators revisited…
Colorado can’t cap price of arthritis drug Enbrel, judge rules
Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging the state’s drug affordability board’s…
Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
Colorado’s first-of-its-kind price cap on an Amgen drug blocked
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
How The Shutdown Impacts Healthcare
In this week’s edition of InnovationRx, we look at the shutdown’s impact on healthcare, the Nobel Prize winners…
These 20 companies still love remote work
Across much of America, workers fear their options for remote work are slipping away. The news cycle churns…
A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)
When investors think about quantum computing stocks, IonQ is often one of the first names that comes to…